Covalent binding of trichloroethylene to proteins in human and rat hepatocytes

Toxicology Letters

Volumn 95, Issue 3, 1998, Pages 173-181

  Griffin, Joseph M ^a   Lipscomb, John C ^b   Pumford, Neil R ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Armstrong Laboratory OL AL HSC/OETA   (United States)

Author keywords

Covalent binding; Cytochrome P450 2E1; Reactive intermediates; Trichloroethylene

Indexed keywords

CYTOCHROME P450; TRICHLOROETHYLENE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; COVALENT BOND; DOSE RESPONSE; DRUG METABOLISM; DRUG TOXICITY; LIVER CELL CULTURE; LIVER TOXICITY; MALE; METABOLITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

EID: 0032079566     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(98)00038-1     Document Type: Article

References (28)

1. Berry M.N., Friend D.S. High-yield preparation of isolated rat liver parenchymal cells. A biochemical and fine structural study. J. Cell Biol. 43:1969;506-520.
2. Bruckner J.V., Davis B.D., Blancato J.N. Metabolism, toxicity, and carcinogenicity of trichloroethylene. Crit. Rev. Toxicol. 20:1989;31-50.
3. Buben J.A., O'Flaherty E.J. Delineation of the role of metabolism in the hepatotoxicity of trichloroethylene and perchloroethylene: a dose-effect study. Toxicol. Appl. Pharmacol. 78:1985;105-122.
4. Davidson I.W., Beliles R.P. Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics. Drug Metab. Rev. 23:1991;493-599.
5. DeAngelo A.B., Daniel F.B., McMillan L., Wernsing P., Savage R.E. Jr. Species and strain sensitivity to the induction of peroxisome proliferation by chloroacetic acids. Toxicol. Appl. Pharmacol. 101:1989;285-298.
6. DelRaso, N.J., 1992. In vitro methods for assessing chemical or drug toxicity and metabolism in primary hepatocytes. In: Watson, R.R. (Ed.), In Vitro Methods of Toxicology. CRC Press, Boca Raton, FL, pp. 175-201.
7. Garrett C.M., Mahle D.A., Lipscomb J.C. Comparison of the in vitro metabolism of trichloroethylene in three species: Rat, mouse and human. Fundam. Appl. Toxicol. 30:1996;318.
8. Goeptar A.R., Commandeur J.N.M., van Ommen B., van Bladeren P.J., Vermeulen N.P.E. Metabolism and kinetics of trichloroethylene in relation to toxicity and carcinogenicity. Relevance of the mercapturic acid pathway. Chem. Res. Toxicol. 8:1995;3-21.
9. Green T. Chloroethylenes: a mechanistic approach to human risk evaluation. Annu. Rev. Pharmacol. Toxicol. 30:1990;73-89.
10. Guengerich F.P., Kim D.H., Iwasaki M. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4:1991;168-179.
11. Halmes N.C., McMillan D.C., Oatis J.E. Jr., Pumford N.R. Immunochemical detection of protein adducts in mice treated with trichloroethylene. Chem. Res. Toxicol. 9:1996;451-456.
12. Halmes N.C., Perkins E.J., McMillan D.C., Pumford N.R. Detection of trichloroethylene-protein adducts in rat liver and plasma. Toxicol. Lett. 92:1997;187-194.
13. Halmes N.C., Samokyszyn V.M., Pumford N.R. Covalent binding and inhibition of cytochrome P4502E1 by trichloroethylene. Xenobiotica. 27:1997;101-110.
14. IARC, 1995. World Health Organization, International Agency for Research on Cancer, Lyon, France, vol. 63, pp. 75-158 .
15. Kenna J.G., Neuberger J., Williams R. An enzyme-linked immunosorbent assay for detection of antibodies against halothane-altered hepatocyte antigens. J. Immunol. Methods. 75:1984;3-14.
16. Kilburn K.H., Warshaw R.H. Prevalence of symptoms of systemic lupus erythematosus (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water. Environ. Res. 57:1992;1-9.
17. Larson J.L., Bull R.J. Species differences in the metabolism of trichloroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate. Toxicol. Appl. Pharmacol. 115:1992;278-285.
18. Lipscomb J.C., Garret C.M., Snawder J.E. Cytochrome P450-dependent metabolism of trichloroethylene - interindividual differences in humans. Toxicol. App. Pharmacol. 142:1997;311-318.
19. Lockey J.E., Kelly C.R., Cannon G.W., Colby T.V., Aldrich V., Livingston G.K. Progressive systemic sclerosis associated with exposure to trichloroethylene. J. Occup. Med. 29:1987;493-496.
20. Nakajima T., Wang R.S., Elovaara E., Park S.S., Gelboin H.V., Vainio H. A comparative study on the contribution of cytochrome P450 isozymes to metabolism of benzene, toluene and trichloroethylene in rat liver. Biochem. Pharmacol. 43:1992;251-257.
21. National Institute for Occupational Safety and Health, 1978. Special Occupational Hazard Review of Trichloroethylene. DHEW Publ. No. 78-130, Washington, DC.
22. Nelson E.B. The pharmacology and toxicology of meta-substituted acetanilide: I. Acute toxicity of 3HAA in mice. Res. Commun. Chem. Pathol. Pharmacol. 28:1980;447-456.
23. Pohl L.R. An immunochemical approach of identifying and characterizing protein targets of toxic reactive metabolites. Chem. Res. Toxicol. 6:1993;786-793.
24. Pumford N.R., Halmes N.C. Protein targets of reactive intermediates of xenobiotics. Annu. Rev. Pharmacol. Toxicol. 37:1997;91-117.
25. Waller P.A., Clauw D., Cupps T., Metcalf J.S., Silver R.M., LeRoy E.C. Fasciitis (not scleroderma) following prolonged exposure to an organic solvent (trichloroethylene). J. Rheumatol. 21:1994;1567-1570.
26. Weiss N.S. Cancer in relation to occupational exposure to trichloroethylene. Occup. Env. Med. 53:1996;1-5.
27. Westrick J.J., Mello J.W., Thomas R.F. The ground water supply survey. J. Am. Water Works Assoc. 76:1984;52-59.
28. Yanez Diaz S., Moran M., Unamuno P., Armijo M. Silica and trichloroethylene-induced progressive systemic sclerosis. Dermatology. 184:1992;98-102.